Abstract
Cardiorespiratory fitness (CRF) is a strong, modifiable predictor of cardiovascular mortality in type 2 diabetes (T2D). Metformin is commonly prescribed for T2D management and is known to impair CRF adaptations to aerobic training, however its effect on CRF adaptations to high-intensity, high velocity resistance training (Power training; POWER) has never been studied.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have